Cargando…
Novel biomarkers for the diagnosis and prognosis of colorectal cancer
Colorectal cancer (CRC) is among the most common malignancies and remains a major cause of cancer-related death worldwide. Despite recent advances in surgical and multimodal therapies, the overall survival of advanced CRC patients remains very low. Cancer progression, including invasion and metastas...
Autores principales: | Oh, Hyung-Hoon, Joo, Young-Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206347/ https://www.ncbi.nlm.nih.gov/pubmed/31766836 http://dx.doi.org/10.5217/ir.2019.00080 |
Ejemplares similares
-
Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
por: Chang, Yu-Chan, et al.
Publicado: (2021) -
Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers
por: Lee, Sung Hak, et al.
Publicado: (2017) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Gutierrez, Alvaro, et al.
Publicado: (2021) -
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis
por: Chen, Bing, et al.
Publicado: (2019) -
Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)